Infantile-onset skeletal myopathy Barth syndrome (OMIM #302060) is caused by mutations in the X-linked TAZ gene and hence usually manifests itself only in hemizygous males. Confirmatory testing is provided by mutational analysis of the TAZ gene and/or by biochemical dosage of the monolysocardiolipin/tetralinoleoyl cardiolipin ratio. Heterozygous females do not usually display a clinical phenotype but may undergo molecular genetic prenatal diagnosis during pregnancy. We characterized two novel and non-identical TAZ gene rearrangements in the offspring of a single female carrier of Barth syndrome. The hg19chrX:g.153634427_153644361delinsKP_123427.1 TAZ gene rearrangement was identified in her affected son, whereas the NM_000116.3(TAZ)c. − 72_109+51del TAZ gene deletion was identified in a male foetus during a subsequent pregnancy. The unaffected mother was surprisingly found to harbour both variants in addition to a wild-type TAZ allele. A combination of breakpoint junction sequencing, linkage analysis and assessment of allelic dosage revealed that the two variants had originated independently from an apparently unstable/mutable TAZ maternal allele albeit via different mutational mechanisms. We conclude that molecular prenatal diagnosis in Barth syndrome families with probands carrying TAZ gene rearrangements should include investigation of the entire coding region of the TAZ gene. The identification of the breakpoint junctions of such gross gene rearrangements is important to ensure accurate ascertainment of carriership with a view to providing appropriate genetic counselling.
INTRODUCTION
Barth syndrome (BTHS; OMIM #302060) is an X-linked, infantileonset inborn error of metabolism characterized by cardiomyopathy with or without left ventricular noncompaction, skeletal myopathy, hypotonia, growth delay and intermittent neutropenia. 1-3 3-Methylglutaconic aciduria and lactic acidosis can represent early biochemical markers. 1, [4] [5] [6] The estimated prevalence of BTHS is around 1/300 000-400 000 live births (BSF, http://www.barthsyndrome.org/home), but evidence is growing that the disease may be underdiagnosed. 2 BTHS is caused by mutations in the TAZ gene at Xq28, 7 which encodes tafazzin, an acyltransferase which promotes molecular symmetry among cardiolipin (CL) species with different fatty acyl moieties. 8, 9 CL is involved in the mitochondrial energy metabolism, mitochondrial dynamics and triggering of apoptotic pathways. 10, 11 In mammalian cardiac and skeletal muscle, the predominant form is tetralinoleoyl cardiolipin (L4-CL). The impairment of tafazzin causes a L4-CL deficiency and an accumulation of intermediate species of monolysocardiolipins (MLCL) leading to profound ultrastructural and functional alterations of mitochondria. 2, [11] [12] [13] Confirmatory tests for the disease are both biochemical and molecular. Biochemical tests rely on the detection of an increased MLCL:L4-CL ratio in blood, tissues or cultured cell samples from patients. 14, 15 Molecular tests involve the mutational analysis of the TAZ gene sequence, which should be considered mandatory as a few TAZ gene mutations that do not lead to abnormal CL levels have recently been described. 16 More than 100 different TAZ gene mutations have been reported in the Human Tafazzin Gene Mutation and Variation Database of the American Barth Syndrome Foundation (http://www.barthsyndrome. org/science-medicine/human-tafazzin-(taz)-gene-mutation-variationdatabase) and~10% of these are gross TAZ gene rearrangements. We have recently shown that the TAZ gene sequence is enriched in interspersed repeats, sequence elements that can promote the formation of gross genetic rearrangements during meiosis or DNA replication. 4, 17 Here we describe the intriguing case of a BTHS family in which an asymptomatic mother gave birth to two male sons who harboured non-identical gross TAZ gene rearrangements. If found not to be uncommon, such 'double hit' situations could complicate the molecular prenatal diagnosis of BTHS.
MATERIALS AND METHODS

Family history
The pedigree of the Italian BTHS family under study is presented in Figure 1 . The proband (IV-L, Figure 1 ) was the first child born to non-consanguineous parents after a previous miscarriage. Owing to a family history of suspected X-linked adrenoleukodystrophy (two deceased maternal uncles; II-C and II-D, Figure 1 ), the mother had elected to undergo prenatal diagnosis for increased very-long-chain fatty acid (VLCFA) levels in cultured amniocytes, but this proved normal. The child (IV-L) was born after 36 weeks gestation. After birth, he exhibited hypotonia and difficulty in suckling. In his first year of life, he manifested three severe single episodes of febrile seizures with ventricular tachycardia. Such manifestations occurred in association with otitis and gastroenteritis. Cardiological investigation revealed dilated cardiomyopathy with left ventricular noncompaction and ventricular arrhythmias. Further medical investigations revealed intermittent neutropenia and lactic acidosis. Anaemia was present and hypoglycaemia was intermittently detected. He started to walk at the age of 2 years although he exhibited reduced muscle tone and staggering. Muscle biopsy, performed as a consequence of the suspicion of a primary defect of the mitochondrial respiratory chain when the patient was 9 years, showed abnormal intracytoplasmic storage of lipids. At the age of 10 years, he came to our attention and BTHS was suspected due to the association of cardiomyopathy, neutropenia, 3-methylglutaconic aciduria and lactic acidosis.
We confirmed the diagnosis by monolysocardiolipin/cardiolipin analysis (MLCL/CL ratio on dried blood spot 14 was 5.51; normal 0-0.3) and by TAZ gene sequencing. At the time of writing, the patient is 11 years. He exhibits frequent episodes of debilitating headaches. Dilated cardiomyopathy and growth delay persist, with both his weight and height being under the 25th percentile.
A second son (IV-M, Figure 1 ) was born when IV-L was 5 years and before a definitive diagnosis had been made. Prenatal evaluation for VLCFA had been performed during pregnancy and was normal. Dilated cardiomyopathy was detected in IV-M on his second day of life. He also exhibited hypotonia, neutropenia and lactic acidosis. He died five and half months after birth due to sudden heart failure.
The mother (III-H in Figure 1 ) had a fourth pregnancy after the definitive diagnosis of BTHS had been made in the proband IV-L. She underwent genetic counselling and prenatal diagnosis for BTHS (IV-N, Figure 1 ).
Mutational analysis of the TAZ gene
Isolation of genomic DNA and molecular analysis of the TAZ gene sequence were performed as previously described, 4 after informed consent had been obtained from all subjects to be analysed, in accordance with local ethical committee recommendations. Multiplex PCR analyses were performed by using our previously reported primer pairs (Table 1 in Ferri et al 4 ). PCR fragment combinations Taz3-4+Taz5+Taz6-7, Taz1-2+Taz8-9 and Taz1-2+Taz10-11 were successfully assayed.
Long-range PCR analysis
Long-range PCR (LR-PCR) using TaKaRa La Taq DNA polymerase (TaKaRa Bio Inc., Shiga, Japan) was performed to determine the precise locations of the breakpoint boundaries in proband IV-L. The primer pair used was DNASE1L-ex10fw (5′-TGACCCTTCTAGCGTCCC-3′) and Taz6-7rv (5′-AGGCCTAGTC TCAGCACCTG-3′). 4 The reverse primer Taz6-7rv anneals within intron 7 of TAZ, which was confirmed to be present in proband IV-L by routine amplification of the TAZ coding region and intron-exon boundaries. Primer DNASE1L-ex10fw anneals 9.95 kb upstream of the start codon (ATG) of the TAZ gene within exon 10 of the DNASE1L gene, which is located in the opposite orientation to, but partially overlaps with, the TAZ gene. The presence of this region in the patient's DNA was previously verified by PCR amplification and sequencing with the primer pair DNASE1L-ex10fw and DNASE1L-ex10rv (5′-GATAGGACACTTGTGCAG-3′), which amplifies a 484 bp fragment of DNASE1L exon 10. LR-PCR products were purified from a 0.8% agarose gel and sequenced by primer-walking. The Clustal W program (http:// www.clustal.org/) was used to align sequences located at the breakpoints. LR-PCR was also used to screen for heterozygous carriership of the hg19chrX:g.153634427_153644361delinsKP_123427.1 complex rearrangement. 
Intra-individual mutational plasticity of TAZ gene L Ferri et al
We combined the primer DNASE1L-ex10fw with primer TAZRNA1F (5′-ATGCCTCTGCACGTGAAGTG-3′), which anneals within TAZ exon 1 and is oriented as the primer DNASE1L-ex10fw in the wild-type TAZ allele ( Figure 2 ). By contrast, in the hg19chrX:g.153634427_153644361delinsKP_ 123427.1 TAZ allele, although the annealing region of TAZRNA1F is present, it is in a reverse complement orientation. For this reason, the primer pair DNASE1L-ex10fw+TAZRNA1F amplifies specifically only the hg19chrX: g.153634427_153644361delinsKP_123427.1 TAZ allele ( Figure 2 ). LR-PCR products obtained from the positive female III-H and the proband IV-L were purified from a 0.8% agarose gel and confirmed by DNA sequencing.
Determination of the X-chromosome linkage and X-inactivation pattern
The proximal region of Xq was tracked by the analysis of the polymorphic CAG repeats of the human androgen receptor gene (AR; Xq12) as previously reported. 18 The distal Xq28 region carrying the TAZ gene was tracked instead by amplification of the two loci DXS8091 and DXS1073 from the ABI Prism Linkage Mapping Set (Applied Biosystems, Carlsbad, CA, USA) following the manufacturer's instructions. DXS8091 and DXS1073 both map to Xq28, upstream and downstream of TAZ, respectively. The X-chromosome inactivation analysis was performed by studying the polymorphic CAG repeats of the AR gene using the methylation-sensitive restriction enzymes HpaII and CfoI as previously reported. 18, 19 Quantitative fluorescent multiplex-PCR (QFM-PCR) of the TAZ gene TAZ exons 1, 4, 6-7, 8-9 and 10-11 were each amplified in a multiplex reaction, together with the ACY12 fragment from Ferri et al 20 as an internal control peak. Primers used are detailed in Table 1 .
Multiplex PCR reactions were performed in a 25 μl final volume containing 1 U FastStart Taq DNA polymerase (Roche, Basel, Switzerland), 250 μM each dNTP, 10 pmol each primer, 1 × PCR buffer and 1.0 mM MgCl 2 . After primary denaturation for 5 min at 95°C, amplification was carried out for 25 cycles of 30 s at 95°C, 30 s at 56°C and 30 s at 72°C. PCR products were denatured for 5 min at 95°C, run on an ABI PRISM 3130XL Genetic Analyser (Applied Biosystems) and sized using the GeneScan 500 LIZ Size Standard (Applied Biosystems) as the internal standard. For each sample, the peak areas of each TAZ fragment were normalized by dividing them by the peak area of the internal control ACY12. Normalized areas were then divided by the average normalized peak area from at least three normal controls. Values ranging from 0.7 to 1.3 were assumed to be normal based on our previous experience. 20, 21 Ten control DNAs and two DNAs from two previously described female relatives of a BTHS patient harbouring a heterozygous deletion of TAZ exons 6-11 (NG_009634.1:g.[9777_9814del; 9911-?_14402del] 4 ) were included in order to validate the assay.
Gene variants nomenclature and reference sequences
Gene variants are given in the text by following the HGVS recommendations (http://www.hgvs.org/mutnomen/). Exon numbering refers to NG_009634.1 (TAZ; Gene ID: 6901) and NG_012884.1 (DNASE1L; Gene ID: 1774). GenBank reference sequences used for the description of gene variants are NM_000116. Figure 2 Representation of the TAZ gene rearrangements identified. Relative locations of the breakpoint junctions of NM_000116.3(TAZ)c. − 72_109+51del and hg19chrX:g.153634427_153644361delinsKP_123427.1. The annealing sites of primers DNASE1L-9fw and TAZRNA1F, which were used to confirm heterozygosity for the hg19chrX:g.153634427_153644361delinsKP_123427.1 variant in the proband's mother, are also indicated. When we analysed the proband's mother's DNA (III-H, Figure 1 ), obtained from peripheral whole blood, we found that she harboured both variants, the NM_000116.3(TAZ)c. − 72_109+51del identical to that detected in her foetus IV-N and the hg19chrX: g.153634427_153644361delinsKP_123427.1, identical to that identified in the proband IV-L. Other female family members, III-I, II-E and I-A (Figure 1) , were tested for both TAZ rearrangements but none of them tested positive. Unfortunately, genotyping of BTHS patient IV-M was not possible, because he died before the family had received the diagnosis of BTHS and no biological material was available for postmortem DNA purification and analysis.
The two distinct mutations originated from rearrangements of the same TAZ allele To determine which TAZ allele(s) had been rearranged to generate the TAZ gene lesions identified, we performed a linkage analysis (Figure 1) . The maternal Xq28 region was found to be shared by both males IV-L and IV-N, although they did not share the Xq proximal region harbouring the AR gene. As the linkage between the AR and DXS markers detected in the foetus IV-N is also evident in his aunt (III-I; Figure 1) , the X-chromosome of IV-M must have arisen by crossing-over.
The X-inactivation studies performed on the proband's mother's DNA (III-H, Figure 1 ) detected an extremely skewed pattern (ratio495:5) in favour of the wild-type allele (267 bp AR fragment; Figure 1 ).
Allelic dosage analysis of TAZ Data obtained from three replicates (Table 2 ) consistently failed to provide any evidence for allelic imbalance of the TAZ exons in the proband's mother's DNA. The efficacy of the method was, however, confirmed by the successful detection of heterozygosity of a TAZ exons 6-11 deletion in two DNAs from females harbouring the previously described NG_009634.1:g.[9777_9814del; 9911-?_14402del] TAZ complex rearrangement. 4 
DISCUSSION
The molecular diagnosis of monogenic inherited diseases is generally based on the detection of variants in the known disease gene of the probands. Once a nucleotide variant that affects the gene function has been detected, at-risk family members can be identified through a targeted search for the segregating familial mutation(s). The same principle pertains with regard to the prenatal molecular diagnosis of at-risk foetuses in the subsequent pregnancies of female carriers. It is in this context that we report the unusual case of a family in which a clinically unaffected mother harboured two novel and quite different TAZ gene rearrangements that were independently inherited by her male offspring (one child and one foetus).
Analysis of the breakpoint junctions of the two novel rearrangements were consistent with the view that they originated via different mutational mechanisms. The NM_000116.3(TAZ)c. − 72_109+51del occurred between two GC-rich regions, possibly through replication slippage. 22 By contrast, the hg19chrX:g.153634427_153644361 delinsKP_123427.1 complex allele does not exhibit significant sequence homology between the breakpoint junctions, suggesting that this rearrangement could have been mediated by double-strand breaks repaired by addition of a DNA stuffer derived from portions of the deleted fragment.
By means of a linkage analysis of the Xq region within the involved family members, we ascertained that the NM_000116.3(TAZ) c. − 72_109+51del and hg19chrX:g.153634427_153644361delinsKP_ 123427.1 rearrangements had originated from the same apparently unstable/mutable maternal TAZ allele. The proband's maternal lineage was also tested, but no other individual (including his grandmother, great grandmother or maternal aunt) harboured any of the identified TAZ variants.
The coexistence of two different TAZ variants in the genome of the unaffected mother could be explicable in terms of somatic and gonadal mosaicism. Alternatively, each maternal cell might carry both variants together with the wild-type TAZ allele. This second hypothesis is inherently unlikely as the male proband and the male foetus were positive for only one TAZ gene rearrangement and did not harbour a normal TAZ allele. Further, under this second hypothesis, an allelic imbalance of TAZ exons 6-11 would be expected in the mother's DNA. As the analysis of allelic dosage that we performed did not reveal any clear-cut imbalance of TAZ exons 6-11 in the mother, somatic and gonadal mosaicism appears to be the more likely explanation in this particular case.
Other examples of co-occurring pathological mutations in relatives have been reported for other X-linked diseases such as Duchenne/ Becker muscular dystrophy [23] [24] [25] [26] [27] and haemophilia A. 28, 29 Similar cases in autosomal genes have also been reported, for example, involving the NF1 gene, 30, 31 the RB1 gene 32 and the APC gene. 33 It remains unclear whether these cases represent examples of mutationally unstable alleles or simply chance co-occurrence.
Both the identified TAZ variants involve deletions of portions of the deoxyribonuclease I-like 1 gene (DNASE1L1), which partially overlaps with TAZ. A similar case has been previously described in a BTHS patient who harboured a deletion of the entire TAZ gene and a partial deletion of DNASE1L. 34 However, no disease has so far been associated with mutation of the DNASE1L1 gene and therefore there is no evidence for any involvement of this gene in the BTHS clinical phenotype. 34 Our observations should be borne in mind when performing molecular diagnosis of BTHS. For instance, when performing molecular prenatal diagnosis of BTHS in families with large TAZ gene rearrangements, we recommend investigating the entire coding region of the TAZ gene by both multiplex PCR amplification of all exons and by direct sequencing. Moreover, additional efforts should be made to develop rapid and simple molecular tools to identify gross genetic rearrangements of the TAZ gene in heterozygous females (eg, MLPA or Real-Time PCR-based assay).
